Delivery Order SPE2DB22D2206-SPE2DB23FKP90
Award Date 9/27/23
Potential Completion Date 10/19/23
Potential Value $68K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $33,928 delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. This firm fixed price order is being fulfilled under an existing Prime Vendor Pharmaceutical contract vehicle and will provide 10ML vials of the multiple sclerosis treatment Ocrevus to support DLA missions. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required by July 31, 2023. No subcontractors or set...
- The Defense Logistics Agency awarded a $22,618.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. The delivery order was issued against an existing Prime Vendor contract vehicle and calls for the delivery of 10 ML vials of Ocrevus, a multiple sclerosis treatment drug, to a facility in Conshohocken, Pennsylvania. Funding is provided by the Defense Logistics Agency to support its medical supply needs. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a $45,237 delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. The firm fixed price order is valued at forty-five thousand two hundred thirty-seven dollars and will be performed in Conshohocken, Pennsylvania under the agency's Pharmaceutical Prime Vendor contract vehicle from August 3rd to August 24th, 2023. Amerisourcebergen will supply the multiple sclerosis treatment to the DLA, which manages the Department of Defense's...
- The Defense Logistics Agency awarded a delivery order under an undisclosed contract vehicle to Amerisourcebergen Drug Corporation for the supply of Ocrevus 300 MG/10 ML vials. Valued at $67,856.16 with a firm fixed price, the order is for 10ML vials of Ocrevus to be delivered to a facility in Conshohocken, Pennsylvania between July 22nd and August 11th, 2023. As a major provider of pharmaceuticals and medical supplies to the U.S. military, the DLA likely issued this order to support treatment of...
- The Defense Logistics Agency awarded a $67,856 delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 10 ML vials of the multiple sclerosis treatment Ocrevus to a facility in Conshohocken, Pennsylvania. Performance will take place between July 14 and August 4, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support the...
- The Defense Logistics Agency awarded a $45,237 delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. Under this firm fixed price contract, Amerisourcebergen will provide 10 mL vials of the multiple sclerosis treatment Ocrevus to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three week period concluding in mid-August. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a $67,856 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. Under this order, Amerisourcebergen will deliver 4562126837 units of the multiple sclerosis treatment to a facility in Conshohocken, Pennsylvania by October 2, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military services and combatant commands. This delivery order was...
- The Defense Logistics Agency awarded a $113,093.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. Under this contract, Amerisourcebergen will deliver 4562277151 units of the multiple sclerosis treatment Ocrevus to locations in Conshohocken, Pennsylvania by October 16, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military services and combatant commands. This...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $45,237.44 to Amerisourcebergen Drug Corporation for the supply of 4562055207 Ocrevus 300 MG/10 ML Vials. Amerisourcebergen will deliver 10ML vials of the multiple sclerosis treatment Ocrevus to a location in Conshohocken, Pennsylvania under a start date of September 5, 2023 concluding on September 26, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. The...
- The Defense Logistics Agency (DLA) awarded a $12,019.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials. The contract was competitively awarded without set-aside provisions and carries an ultimate completion date of September 18, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...